Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2821793-99-9
2. 3nq4me292x
3. Refchem:1098491
4. Kras G12d Inhibitor 17
5. Setidegrasib [inn]
6. Orb1982739
7. Schembl26963151
8. Schembl29860092
9. Yqf2672
10. A1l66
11. Ex-a11454
12. Da-54678
13. Hy-148273
14. Cs-0618100
15. En300-44826014
16. (2s,4r)-1-((2s)-2-(4-(4-(((4-((1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-6-cyclopropyl-7-(6-fluoro-5-methyl-1h-indazol-4-yl)-2-((tetrahydro-2h-pyran-4-yl)oxy)quinazolin-8-yl)oxy)methyl)phenyl)-1h-1,2,3-triazol-1-yl)-3-methylbutanoyl)-4-hydroxy-n-((r)-2-hydroxy-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide
17. (2s,4r)-1-[(2s)-2-(4-{4-[({6-cyclopropyl-4-[(1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1h-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl}oxy)methyl]phenyl}-1h-1,2,3-triazol-1-yl)-3-methylbutanoyl]-4-hydroxy-n-[(1r)-2-hydroxy-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
18. (2s,4r)-1-[(2s)-2-[4-[4-[[6-cyclopropyl-4-[(1s,4s)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1h-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]phenyl]triazol-1-yl]-3-methylbutanoyl]-4-hydroxy-n-[(1r)-2-hydroxy-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
19. 2-pyrrolidinecarboxamide, 1-[(2s)-2-[4-[4-[[[6-cyclopropyl-4-(1s,4s)-2,5-diazabicyclo[2.2.1]hept-2-yl-7-(6-fluoro-5-methyl-1h-indazol-4-yl)-2-[(tetrahydro-2h-pyran-4-yl)oxy]-8-quinazolinyl]oxy]methyl]phenyl]-1h-1,2,3-triazol-1-yl]-3-methyl-1-oxobutyl]-4-hydroxy-n-[(1r)-2-hydroxy-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (2s,4r)-
| Molecular Weight | 1117.3 g/mol |
|---|---|
| Molecular Formula | C60H65FN12O7S |
| XLogP3 | 7.7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 17 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 259 |
| Heavy Atom Count | 81 |
| Formal Charge | 0 |
| Complexity | 2130 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
21
PharmaCompass offers a list of Setidegrasib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Setidegrasib manufacturer or Setidegrasib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Setidegrasib manufacturer or Setidegrasib supplier.
A Setidegrasib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Setidegrasib, including repackagers and relabelers. The FDA regulates Setidegrasib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Setidegrasib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Setidegrasib supplier is an individual or a company that provides Setidegrasib active pharmaceutical ingredient (API) or Setidegrasib finished formulations upon request. The Setidegrasib suppliers may include Setidegrasib API manufacturers, exporters, distributors and traders.
Setidegrasib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Setidegrasib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Setidegrasib GMP manufacturer or Setidegrasib GMP API supplier for your needs.
A Setidegrasib CoA (Certificate of Analysis) is a formal document that attests to Setidegrasib's compliance with Setidegrasib specifications and serves as a tool for batch-level quality control.
Setidegrasib CoA mostly includes findings from lab analyses of a specific batch. For each Setidegrasib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Setidegrasib may be tested according to a variety of international standards, such as European Pharmacopoeia (Setidegrasib EP), Setidegrasib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Setidegrasib USP).
